UNIQURE NV's ticker is QURE and the CUSIP is N90064101. A total of 133 filers reported holding UNIQURE NV in Q1 2019. The put-call ratio across all filers is 0.11 and the average weighting 0.4%.
Links
Filings
- All filings
- Annual reports (10-K)
- Quarterly reports (10-Q)
- Insider transactions
- Shareholder votes
- Significant ownership
- Events
EDGAR links
External links
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2019 | $13,000 | +160.0% | 189 | +58.8% | 0.00% | – |
Q3 2019 | $5,000 | -37.5% | 119 | +15.5% | 0.00% | – |
Q2 2019 | $8,000 | +33.3% | 103 | +3.0% | 0.00% | – |
Q1 2019 | $6,000 | -96.2% | 100 | -98.2% | 0.00% | -100.0% |
Q4 2018 | $159,000 | -12.6% | 5,500 | +10.0% | 0.00% | -50.0% |
Q3 2018 | $182,000 | +21.3% | 5,000 | -21.9% | 0.00% | +100.0% |
Q2 2018 | $150,000 | 0.0% | 6,400 | 0.0% | 0.00% | 0.0% |
Q1 2018 | $150,000 | +354.5% | 6,400 | +276.5% | 0.00% | – |
Q4 2017 | $33,000 | +266.7% | 1,700 | +229.5% | 0.00% | – |
Q4 2015 | $9,000 | +200.0% | 516 | +209.0% | 0.00% | – |
Q3 2015 | $3,000 | – | 167 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Aquilo Capital Management, LLC | 841,471 | $15,786,000 | 5.69% |
Nantahala Capital Management | 2,901,929 | $54,440,000 | 3.52% |
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 544,500 | $10,209,000 | 3.27% |
683 Capital Management, LLC | 1,373,600 | $25,768,000 | 1.99% |
PFM Health Sciences, LP | 2,393,311 | $44,899,000 | 1.62% |
Integral Health Asset Management, LLC | 433,000 | $8,123,000 | 1.58% |
Privium Fund Management B.V. | 238,998 | $4,283,000 | 1.56% |
Nantahala Capital Management | 1,000,000 | $18,760,000 | 1.21% |
Henry James International Management Inc. | 89,469 | $1,678,000 | 0.94% |
Altium Capital Management LP | 105,000 | $1,970,000 | 0.72% |